Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person IPI-504 [cytosol]

Class:IdChemicalDrug:1217514
_displayNameIPI-504 [cytosol]
_timestamp2019-05-13 21:13:10
compartment[Compartment:70101] cytosol
created[InstanceEdit:1217513] Orlic-Milacic, Marija, 2011-02-17
crossReference[DatabaseIdentifier:9628103] ChEBI:71956
disease[Disease:1500689] cancer
literatureReference[LiteratureReference:3002825] IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells
modified[InstanceEdit:1220598] Orlic-Milacic, Marija, 2011-02-22
[InstanceEdit:1247626] Orlic-Milacic, Marija, 2011-04-04
[InstanceEdit:1667319] Orlic-Milacic, Marija, 2011-10-14
[InstanceEdit:2203442] Orlic-Milacic, M, 2012-04-20
[InstanceEdit:3002828] Orlic-Milacic, M, 2013-01-28
[InstanceEdit:3004607] Orlic-Milacic, M, 2013-01-29
[InstanceEdit:9016686] Orlic-Milacic, Marija, 2017-08-14
[InstanceEdit:9016766] Orlic-Milacic, Marija, 2017-08-15
[InstanceEdit:9016804] Orlic-Milacic, Marija, 2017-08-15
[InstanceEdit:9028147] Weiser, JD
[InstanceEdit:9616752] Shorser, Solomon, 2018-08-13
[InstanceEdit:9619952] Wu, G, 2018-09-19
[InstanceEdit:9627975] Wu, G, 2018-11-05
[InstanceEdit:9631716] Wu, G, 2018-12-12
[InstanceEdit:9645624] Orlic-Milacic, Marija, 2019-05-13
nameIPI-504
retaspimycin hydrochloride
referenceEntity[ReferenceTherapeutic:9645622] retaspimycin hydrochloride [Guide to Pharmacology:9827]
stableIdentifier[StableIdentifier:2018178] R-ALL-1217514.3
(hasMember)[DefinedSet:1217511] Benzoquinoid ansamycins [cytosol]
(updatedInstance)[_UpdateTracker:9900773] Update Tracker - [ChemicalDrug:1217514] IPI-504 [cytosol] - v70:[add_removeReferenceEntity]
[Change default viewing format]
No pathways have been reviewed or authored by IPI-504 [cytosol] (1217514)
Follow Reactome